Yıl: 2023 Cilt: 6 Sayı: 1 Sayfa Aralığı: 157 - 163 Metin Dili: İngilizce DOI: 10.53446/actamednicomedia.1227630 İndeks Tarihi: 16-06-2023

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY

Öz:
Objective: Granulomatosis with polyangiitis (GPA) is one of the systemic vasculitis included in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV). Clinical characteristics, ANCA serotypes, and their frequencies vary depending on the type of vasculitis. In this study, we aimed to investigate the link between ANCA serotypes and clinical variables documented at the time of admission. Methods:This study was a retrospective cross-sectional study including 40 patients with GPA. The demographic, clinical, laboratory, and radiological findings were extracted from medical records. Logistic Regression Analysis was performed to estimate the relationship between ANCA serotypes and other variables. Results: The mean age was 53.95±12.94 years, and there was a delay of 15.85±23.03 months in diagnosis. While constitutional symptoms were observed in 42% of patients, symptoms related to ear-nose-throat in 70%, lung in 87.5%, kidney in 62.5%, neurological findings in 30%, eye in 25%, skin in 25% and musculoskeletal system findings in 90% were noted. Male gender was seen more frequently in cANCA (60.7%) positive patients; however, pANCA-positive patients were mainly female (83.3%) (p=0.050). Delay in diagnosis was longer (p=0.001) and subglottic stenosis was more common (p<0.001) in pANCA-positive patients. However, the inflammatory response was more severe, and renal involvement (p=0.007) and arthralgia (p=0.048) were higher in cANCA-positive patients. Conclusion: While renal involvement seemed to be related to cANCA, subglottic stenosis was mostly associated with pANCA in GPA. However, larger studies are needed to make a more accurate conclusion about the effect of ANCA serotypes on diversity in the clinical spectrum.
Anahtar Kelime: Granulomatosis with polyangiitis vasculitis antineutrophil cytoplasmic antibody renal involvement subglottic

ANTİNÖTROFİL SİTOPLAZMİK ANTİKOR SEROTİPLERİ GRANÜLOMATÖZ POLİANJİİTLİ HASTALARDA KLİNİK PREZANTASYONU ETKİLEYEBİLİR: TEK MERKEZ, RETROSPEKTİF KESİTSEL ÇALIŞMA

Öz:
Amaç: Granülomatöz polianjiit (GPA) antinötrofil sitoplazmik antikor (ANCA) ilişkili vaskülitlerden (AİV) biridir. Vaskülitin tipine bağlı olarak klinik özellikler, ANCA serotipleri ve sıklıkları değişmektedir. Bu çalışmada, ANCA serotipleri ile başvuru anındaki klinik değişkenler arasındaki ilişkinin araştırılması amaçlandı. Yöntem: Bu retrospektif kesitsel çalışmaya 40 GPA hastası dahil edildi. Demografik, klinik, laboratuar ve radyolojik bulgular hastaların dosyalarından toplandı. ANCA serotipleri ile diğer değişkenlerin ilişkisini değerlendirmek için Logistic Regresyon analizi kullanıldı. Bulgular: Hastaların ortalama yaşları 53,95±12,94 yıl olup tanıda 15,85±23,03 aylık bir gecikme vardı. Konstitüsyonel semptomlar %42 hastada gözlenirken %70’inde kulak-burun-boğaz, %87,5’inde akciğer, %62,5’inde böbrek, %30’unda nörolojik, %25’inde göz, %25’inde cilt ve %90’ında kas-iskelet sistemi ile ilişkili semptomlar kaydedildi. cANCA pozitif olanlarda erkekler daha sık iken (%60,7) pANCA pozitiflerde kadınlar daha fazla (%83,3) idi (p=0.050). pANCA pozitif hastalarda tanıda gecikme daha uzun (p=0.001) ve subglottik stenoz daha sıktı (p<0.001). Bunun yanında cANCA pozitif hastalarda inflamatuar yanıt daha şiddetli ve böbrek tutulumu (p=0.007) ile artralji (p=0.048) daha fazlaydı. Sonuç: GPA’da cANCA böbrek tutulumu ile ilişkili görünürken subglottik stenoz daha çok pANCA ile ilişkiliydi. Bununla birlikte ANCA serotiplerinin klinik spektrumdaki çeşitlilik üzerindeki etkisi hakkında daha doğru bir sonuca varmak için daha büyük çalışmalara ihtiyaç vardır.
Anahtar Kelime: Granülomatöz polyanjiit vaskulit antinötrofil sitoplazmik antikor böbrek tutulumu subglottic stenoz

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Salvador F. ANCA associated vasculitis. Eur J Intern Med. 2020;74:18-28. doi:10.1016/j.ejim.2020.01.011
  • 2. Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF. Classifcation, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)- associated vasculitis. Nephrol Dial Transplant. 2015;30 (suppl 1):i14-22. doi:10.1093/ndt/gfv022
  • 3. Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibodyassociated vasculitis between Japan and the U.K. Rheumatology (Oxford) 2011;50(10):1916-1920. doi:rheumatology/ker205
  • 4. Puechal X. Granulomatosis with polyangiitis (Wegener’s). Joint Bone Spine 2020;87(6):572-578. doi:10.1016/j.jbspin.2020.06.005
  • 5. Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primer. 2020;6(1):71. doi:10.1038/s41572-020-0204-y
  • 6. Grygiel-Gorniak B, Limphaibool N, Perkowska K, Puszczewicz. Clinical manifestations of granulomatosis with polyangiitis: key considerations and majör features. Postgrad Med. 2018;130(7):581-596. doi:00325481. 2018.1503920
  • 7. Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680-1691. doi:10.2215/CJN.02500317
  • 8. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1- 11. doi:10.1007/s10157-013-0869-6
  • 9. Ghorbel B, Belfeki N, Baouendi N, Salem TB, Houman M. Granulomatosis with polyangiitis in Tunisia. Rheumatismo. 2017;69(1):23-29. doi:10.4081/reumatismo.2017.935
  • 10. Bajema IM, Hagen EC, van der Woude FJ, Bruijn JA. Wegener’s granulomatosis: A meta-analysis of 349 literary case reports. J Lab Clin Med. 1997;129(1):17-22. doi:10.1016/S0022-2143(97)90157-8
  • 11. Stone JH. Wegener's granulomatosis etanercept trial research group. Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003;48(8):2299-2309. doi:10.1002/ art.11075
  • 12. Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U. ANCAassociated vasculitis-clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12(10):570-579. doi:10.1038/nrrheum.2016.123
  • 13. Franssen CF, Stegeman CA, Kallenberg CG, et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57(6):2195-2206. doi:10.1046/j.1523-1755.2000.00080.x
  • 14. Quinn KA, Gelbard A, Sibley C, et al. Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. Rheumatology (Oxford). 2019;58(12):2203-2211. doi:10.1093/rheumatology/kez217
  • 15. Greco A, Marinelli C, Fusconi M, et al. Clinical manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol. 2016;29(2):151-159. doi:10.1177/0394632015617063
  • 16. Schirmer JH, Wright MN, Herrmann K, et al. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis with Polyangiitis (Wegener's) is a clinically distinct subset of ANCAassociated vasculitis: A retrospective analysis of 315 patients from a German Vasculitis Referral Center. Arthritis Rheumatol. 2016;68(12):2953-2963. doi:10.1002/art.39786
  • 17. Romero-Gomez C, Aguliar-Garcia JA, Garcia-de-Lucas MD, et al. Epidemiological study of primary systemic vasculitidies among adults in southern Spain and review of the main epidemiological studies. Clin Exp Rheumatol. 2015;33 (Suppl 89):11-18.
  • 18. Cuchacovich R. Immunopathogenesis of vasculitis. Curr Rheumatol Rep. 2002;4(1):9-17. doi:10.1007/s11926-002- 0018-9
APA Yazici A, Sadioğlu çağdaş Ö, ARISAL A, Özdemir Işık Ö, Gokcen N, CEFLE A (2023). ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. , 157 - 163. 10.53446/actamednicomedia.1227630
Chicago Yazici Ayten,Sadioğlu çağdaş Öznur,ARISAL ALI OSMAN,Özdemir Işık Özlem,Gokcen Neslihan,CEFLE Ayse ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. (2023): 157 - 163. 10.53446/actamednicomedia.1227630
MLA Yazici Ayten,Sadioğlu çağdaş Öznur,ARISAL ALI OSMAN,Özdemir Işık Özlem,Gokcen Neslihan,CEFLE Ayse ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. , 2023, ss.157 - 163. 10.53446/actamednicomedia.1227630
AMA Yazici A,Sadioğlu çağdaş Ö,ARISAL A,Özdemir Işık Ö,Gokcen N,CEFLE A ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. . 2023; 157 - 163. 10.53446/actamednicomedia.1227630
Vancouver Yazici A,Sadioğlu çağdaş Ö,ARISAL A,Özdemir Işık Ö,Gokcen N,CEFLE A ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. . 2023; 157 - 163. 10.53446/actamednicomedia.1227630
IEEE Yazici A,Sadioğlu çağdaş Ö,ARISAL A,Özdemir Işık Ö,Gokcen N,CEFLE A "ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY." , ss.157 - 163, 2023. 10.53446/actamednicomedia.1227630
ISNAD Yazici, Ayten vd. "ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY". (2023), 157-163. https://doi.org/10.53446/actamednicomedia.1227630
APA Yazici A, Sadioğlu çağdaş Ö, ARISAL A, Özdemir Işık Ö, Gokcen N, CEFLE A (2023). ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. Acta Medica Nicomedia, 6(1), 157 - 163. 10.53446/actamednicomedia.1227630
Chicago Yazici Ayten,Sadioğlu çağdaş Öznur,ARISAL ALI OSMAN,Özdemir Işık Özlem,Gokcen Neslihan,CEFLE Ayse ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. Acta Medica Nicomedia 6, no.1 (2023): 157 - 163. 10.53446/actamednicomedia.1227630
MLA Yazici Ayten,Sadioğlu çağdaş Öznur,ARISAL ALI OSMAN,Özdemir Işık Özlem,Gokcen Neslihan,CEFLE Ayse ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. Acta Medica Nicomedia, vol.6, no.1, 2023, ss.157 - 163. 10.53446/actamednicomedia.1227630
AMA Yazici A,Sadioğlu çağdaş Ö,ARISAL A,Özdemir Işık Ö,Gokcen N,CEFLE A ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. Acta Medica Nicomedia. 2023; 6(1): 157 - 163. 10.53446/actamednicomedia.1227630
Vancouver Yazici A,Sadioğlu çağdaş Ö,ARISAL A,Özdemir Işık Ö,Gokcen N,CEFLE A ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY. Acta Medica Nicomedia. 2023; 6(1): 157 - 163. 10.53446/actamednicomedia.1227630
IEEE Yazici A,Sadioğlu çağdaş Ö,ARISAL A,Özdemir Işık Ö,Gokcen N,CEFLE A "ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY." Acta Medica Nicomedia, 6, ss.157 - 163, 2023. 10.53446/actamednicomedia.1227630
ISNAD Yazici, Ayten vd. "ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SEROTYPES MAY AFFECT THE CLINICAL PRESENTATION OF PATIENTS WITH POLYANGIITIS: A SINGLECENTER, RETROSPECTIVE CROSS-SECTIONAL STUDY". Acta Medica Nicomedia 6/1 (2023), 157-163. https://doi.org/10.53446/actamednicomedia.1227630